During this round-table discussion our speakers will share their thoughts on the key areas that company leaders need to get right in order to achieve success - above and beyond excellent science. This includes an evolving strategy, deliverable targets, establishing a safe and inclusive environment, engaging in mutually beneficially collaborations that can transform R&D, being open to and adopting new technologies and complying with new standards and regulations.  

After introductory keynotes, we will invite guests to contribute to a round-table discussion on whether a company's expectation of success meets that of the industry. 

Programme:

08.30 - 09.00   Guest arrival and breakfast served

09.00 - 09.30   Introductions & keynotes from:

Introduction from Stuart Rose, CEO of OBN

Keynotes from:

• Matthew Beard PhD, Senior Director External Innovation at Ipsen
• Sarah Pollitt,  Independent Pharma & Healthcare Strategic Advisor
• David Llewellyn, Managing Director at DJS Antibodies

09.30 - 10.30    Round table discussion with all guests and speakers, facilitated by OBN

About OBN's C-Suite Events:

OBN's round table C-Suite Events are designed exclusively for senior C-Suite leaders (or equivalent) from life sciences organisations, whether R&D or those involved in providing critical support services to the industry.

The purpose of these events is to generate some interesting, useful, high-level and boundary pushing discussion and debate, that creates some practical thought-leadership output.

Please note that places are limited and will be offered on an approval only basis.